About MS – Third Edition

This publication provides an overview of multiple sclerosis (MS) and its symptoms, information about treatments, and the programs and services available from MSAA. The reprinting of this publication was made […]

Read News Article

MSAA Expands National Reach of Research Initiative to More than 1,000 Participants Across 20 Locations

The Multiple Sclerosis Association of America (MSAA) is proud to announce the expansion and important milestone of the Multiple Sclerosis Implementation Network (MSIN), enrolling more than 1,000 participants across 20 sites nationwide. MSIN is a patient-driven collaboration that connects MS care centers throughout the United States. By sharing data and insights, participating centers can learn from each other to enhance care and improve outcomes for people living with multiple sclerosis.

Read News Article
Episode 23: Rebuilding the Continuum of MS Care

Episode 23: Rebuilding the Continuum of MS Care

The Multiple Sclerosis Association of America is pleased to present our podcast episode “Rebuilding the Continuum of MS Care.” Hosted by Kimberlee Baugh, Manager of Health Education and Equity at MSAA, this episode addresses how understanding the barriers to MS care in one state in the country, Arizona, reflects the national landscape of anyone impacted by multiple sclerosis. Our guests are Barry Hendin, MD – an MS specialist and MSAA’s Chief Medical Officer – and Tina Brown, a patient advocate living with MS. During this episode, our host and guests discuss recognizing the importance of early diagnosis, share practical solutions to common barriers in MS care, and explore ways stakeholders can work together to improve outcomes for people affected by MS.

Read News Article

What’s New in MS Research – May 2026

Multiple sclerosis was front and center when neurologists from across the country and around the world convened in Chicago in April for the annual meeting of the American Academy of Neurology (AAN).

Researchers presented the results of more than 190 MS-focused studies during the meeting. They shared key data on investigational and approved disease-modifying therapies, factors that affect the course of MS, the impact of co-existing health conditions and the medications used to treat them, and approaches to symptom management. And, of course, no medical meeting these days is complete without reports on how artificial intelligence, or AI, is reshaping care.

Read News Article